Cardiovascular Side Effects of Diethylstilbestrol, Cyproterone Acetate, Medroxyprogesterone Acetate and Estramustine Phosphate Used for the Treatment of Advanced Prostatic Cancer: Results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762-Reference-Cited by-同舟云学术

Cardiovascular Side Effects of Diethylstilbestrol, Cyproterone Acetate, Medroxyprogesterone Acetate and Estramustine Phosphate Used for the Treatment of Advanced Prostatic Cancer: Results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762

Published:1986-02 Issue:2 Volume:135 Page:303-307
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

de Voogt Herman J.¹²³⁴,Smith Philip H.¹²³⁴,Pavone-Macaluso Michele¹²³⁴,de Pauw Marleen¹²³⁴,Suciu Stefan¹²³⁴,

Affiliation:

1. From the Free University, Amsterdam, The Netherlands

2. St. James’s University Hospital, Leeds, United Kingdom

3. University of Palermo, Palermo, Italy

4. European Organization for Research on Treatment of Cancer Data Center, Brussels, Belgium

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference17 articles.

1. EORTC protocols in prostatic cancer. An interim report;Pavone-Macaluso;Scand. J. Urol. Nephrol.,1980

2. Preliminary results of two EORTC randomized trials in previously untreated patients with advanced T3–T4 prostatic cancer;de Pauw,1983

3. Medroxyprogesterone acetate in the treatment of prostatic cancer: preliminary results of EORTC trial 30761 comparing medroxyprogesterone acetate with stilbestrol and with cyproterone acetate;Pavone-Macaluso,1983

4. EORTC protocols in prostatic cancer;Smith,1984

5. Smith, P. H., Suciu, S., Robinson, M. R. G., Richards, B., Bastable, J. R. G., Glashan R. W., Bouffioux, C., Lardennois, B., Williams, R. E., de Pauw, M. and Sylvester, R.: A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the EORTC urological group. J. Urol., submitted for publication.

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Pros and Cons of Estrogens in Prostate Cancer: An Update with a Focus on Phytoestrogens;Biomedicines;2024-07-23

2. Pharmacological Treatment of Perianal Gland Tumors in Male Dogs;Animals;2023-01-28

3. 2020 Korean guidelines for the management of metastatic prostate cancer;The Korean Journal of Internal Medicine;2021-05-01

4. A safety evaluation of current medications for adult women with the polycystic ovarian syndrome not pursuing pregnancy;Expert Opinion on Drug Safety;2020-11-05

5. Impact of Human SULT1E1 Polymorphisms on the Sulfation of 17β-Estradiol, 4-Hydroxytamoxifen, and Diethylstilbestrol by SULT1E1 Allozymes;European Journal of Drug Metabolism and Pharmacokinetics;2020-10-16